Defining the appropriate radiation dose for pretreatment PSA ≤ 10 ng/mL prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 3, 2000, Pages 649-654

  Pinover, Wayne H ^a   Hanlon, Alexandra L ^a   Horwitz, Eric M ^a   Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Dose escalation; Prostate cancer; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; DOSE CALCULATION; DOSE RESPONSE; DOSIMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 0034213117     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00465-X     Document Type: Article

References (28)

1. Consensus statement Guidelines for PSA following radiation therapy . Int J Radiat Oncol Biol Phys. 37:1997;1035-1041.
2. Hanks G.E., Lee W.R., Hanlon A.L., et al. Conformal technique dose escalation for prostate cancer Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen >10 ng/mL . Int J Radiat Oncol Biol Phys. 35:1996;861-868.
3. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
4. Pollack A., Zagars G.K. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys. 39:1997;1011-1018.
5. Roach M., Meehan S., Kroll S., et al. Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. J Urol. 156:1996;1719-1723.
6. Fukunaga-Johnson N., Sandler H.M., McLaughlin P.W., et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys. 38:1997;311-317.
7. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment Five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:1998;501-510.
8. Beahrs OH, Henson DE, Hutter RVP; et al. Manual for staging of cancer. Philadelphia: J. B. Lippincott; 1992. p. 487-512.
9. Pinover W.H., Hanlon A.L., Lee W.R., et al. Prostate cancer patients upstaged by imaging and treated with irradiation An outcome based analysis . Cancer. 77:1996;1334-1341.
10. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. ICRU Report 1993;50:29-33.
11. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
12. Cox D.R. Regression models and life tables. J Roy Stat Soc. 34:1972;187-220.
13. Forman J.D., Duclos M., Sharma R., et al. Conformal mixed neutron and photon irradiation in localized and locally advanced prostate cancer Preliminary estimates of the therapeutic ratio . Int J Radiat Oncol Biol Phys. 35:1996;259-266.
14. Shipley W.U., Verhey L.J., Munzenrider J.E., et al. Advanced prostate cancer The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone . Int J Radiat Oncol Biol Phys. 32:1995;3-12.
15. Ragde H., Elgamal A.A., Snow P.B., et al. Ten-year disease free survival after transperineal sonography-guided Iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer. 83:1998;989-1001.
16. Stromberg J.S., Martinez A.A., Horwitz E.M., et al. Conformal high dose rate Iridium-192 boost brachytherapy in locally advanced prostate cancer Superior prostate-specific antigen response compared with external beam treatment . Cancer J Sci Am. 3:1997;346-352.
17. Forman J.D., Duclos M., Shamsa F., et al. Hyperfractionated conformal radiotherapy in locally advanced prostate cancer Results of a dose escalation study . Int J Radiat Oncol Biol Phys. 34:1996;655-662.
18. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 337:1997;295-300.
19. Pilepich M.V., Krall J.M., Al-Sarraf M., et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma A randomized comparative trial of the Radiation Therapy Oncology Group . Urol. 45:1995;616-623.
20. Pilepich M.V., Caplan R., Byhardt R.W., et al. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy Report of Radiation Therapy Oncology Group Protocol 85-31 . J Clin Oncol. 15:1997;1013-1021.
21. Soffen E.M., Hanks G.E., Hunt M.A., et al. Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques A reduction in acute morbidity . Int J Radiat Oncol Biol Phys. 24:1992;485-488.
22. Lee W.R., Hanks G.E., Schultheiss T.E., et al. Localized prostate cancer treated by external-beam radiotherapy alone Serum prostate-specific antigen-driven outcome analysis . J Clin Oncol. 13:1995;464-469.
23. Corn B.W., Hanks G.E., Schultheiss T.E., et al. Conformal treatment of prostate cancer with improved targeting Superior prostate-specific antigen response compared to standard treatment . Int J Radiat Oncol Biol Phys. 32:1995;325-330.
24. Pollack A., Zagars G.K., Starkschall G., et al. Conventional vs conformal radiotherapy for prostate cancer Preliminary results of dosimetry and acute toxicity . Int J Radiat Oncol Biol Phys. 34:1996;555-564.
25. Zelefsky M.J., Leibel S.A., Kutcher G.J., et al. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. Cancer J Sci Am. 1:1995;142-150.
26. Anderson P.R., Hanlon A.L., Patchefsky A., et al. Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy. Int J Radiat Oncol Biol Phys. 41:1998;1087-1092.
27. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized dose-escalation study comparing 70 Gy to 78 Gy for the treatment of prostate cancer. (abstract) Int J Radiat Oncol Biol Phys. 45:1999;146-147.
28. Michalski J.M., Purdy J.A., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. (abstract) Int J Radiat Oncol Biol Phys. 42:1998;142.